Literature DB >> 23255617

Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1.

Julia Perttilä1, Pirjo Spuul1, Tero Ahola1.   

Abstract

Hepatitis E virus (HEV) is a positive-strand RNA virus and a major causative agent of acute sporadic and epidemic hepatitis. HEV replication protein is encoded by ORF1 and contains the predicted domains of methyltransferase (MT), protease, macro domain, helicase (HEL) and polymerase (POL). In this study, the full-length protein pORF1 (1693 aa) and six truncated variants were expressed by in vitro translation and in human HeLa and hepatic Huh-7 cells by using several vector systems. The proteins were visualized by three specific antisera directed against the MT, HEL and POL domains. In vitro translation of full-length pORF1 yielded smaller quantities of two fragments. However, these fragments were not observed after pORF1 expression and pulse-chase studies in human cells, and their production was not dependent on the predicted protease domain in pORF1. The weight of evidence supports the proposition that pORF1 is not subjected to specific proteolytic processing, which is unusual among animal positive-strand RNA viruses but common for plant viruses. pORF1 was membrane associated in cells and localized to a perinuclear region, where it partially overlapped with localization of the endoplasmic reticulum (ER) marker BAP31 and was closely interspersed with staining of the ER-Golgi intermediate compartment marker protein ERGIC-53. Co-localization with BAP31 was enhanced by treatment with brefeldin A. Therefore, HEV may utilize modified early secretory pathway membranes for replication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255617     DOI: 10.1099/vir.0.049577-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

Review 1.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 2.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 3.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 4.  Hepatitis E Virus Genome Structure and Replication Strategy.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

5.  Activities of Thrombin and Factor Xa Are Essential for Replication of Hepatitis E Virus and Are Possibly Implicated in ORF1 Polyprotein Processing.

Authors:  Gayatri D Kanade; Kunal D Pingale; Yogesh A Karpe
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 6.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

7.  First Crystal Structure of a Nonstructural Hepatitis E Viral Protein Identifies a Putative Novel Zinc-Binding Protein.

Authors:  Andrew Proudfoot; Anastasia Hyrina; Meghan Holdorf; Andreas O Frank; Dirksen Bussiere
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

8.  Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies.

Authors:  Pradip B Devhare; Swapnil Desai; Kavita S Lole
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 9.  Hepatitis E Virus Mutations: Functional and Clinical Relevance.

Authors:  Hoang van Tong; Nghiem Xuan Hoan; Bo Wang; Heiner Wedemeyer; C-Thomas Bock; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-08-06       Impact factor: 8.143

10.  An essential RNA element resides in a central region of hepatitis E virus ORF2.

Authors:  Suzanne U Emerson; Hanh T Nguyen; Udana Torian; Karly Mather; Andrew E Firth
Journal:  J Gen Virol       Date:  2013-03-20       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.